Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115387) titled 'A Clinical Study on Early Screening of Amyotrophic Lateral Sclerosis Based on the Discoidin Domain Receptor 2 (DDR2 )Target' on Dec. 25, 2025.
Study Type: Diagnostic test
Study Design:
Diagnostic test: case-control
Primary Sponsor: The People's Hospital of Baiyun District Guangzhou
Condition:
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of motor neurons in the cortex, brainstem, and spinal cord, leading to muscle atrophy, paralysis, and ultimately respiratory failure.
Intervention:
Gold Standard:Both sets of PET/MR images were acquired by Gu...